Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Patel, Anand
One or more keywords matched the following properties of
Patel, Anand
Property
Value
keywords
Leukemia, Myeloid, Acute
One or more keywords matched the following items that are connected to
Patel, Anand
Item Type
Name
Academic Article
FOXM1 contributes to treatment failure in acute myeloid leukemia.
Academic Article
Impact of race on outcomes in intermediate-risk acute myeloid leukemia.
Academic Article
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes.
Academic Article
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
Academic Article
The Cup Runneth Over: Treatment Strategies for Newly Diagnosed Acute Myeloid Leukemia.
Academic Article
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Academic Article
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
Academic Article
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Academic Article
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Academic Article
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Academic Article
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Academic Article
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Search Criteria
Leukemia Myeloid